Browsing Category

Healthcare operations

50 posts
Arch Biopartners Receives Central IRB Approval To Support U.S. Sites In Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial Of LSALT Peptide

Arch Biopartners Receives Central IRB Approval To Support U.S. Sites In Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial Of LSALT Peptide

Arch Biopartners receives Central IRB approval to support U.S. sites in Phase II trial of LSALT peptide for cardiac surgery-related kidney injury.
WuXi AppTec Continues To Reward Shareholders, Further Increasing Interim Dividend To RMB 1.51 Billion

WuXi AppTec Continues To Reward Shareholders, Further Increasing Interim Dividend To RMB 1.51 Billion

WuXi AppTec has announced a further increase in its interim dividend to RMB 1.51 billion, continuing its shareholder reward strategy amid strong financial performance.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China

HUTCHMED announces trial results showing notable progression-free survival benefits with ORPATHYS® plus TAGRISSO® in lung cancer patients in China.
iBio, Inc. Files 8-K

iBio, Inc. Files 8-K

iBio, Inc. has filed an 8-K with the SEC, disclosing recent corporate updates. Details are now available for investors and stakeholders.
Xenon To Highlight Phase 3 X-TOLE2 Clinical Data And Rational Polytherapy Potential For Azetukalner At EEC 2026

Xenon To Highlight Phase 3 X-TOLE2 Clinical Data And Rational Polytherapy Potential For Azetukalner At EEC 2026

Xenon Pharmaceuticals will showcase Phase 3 X-TOLE2 clinical trial results and discuss polytherapy potential for Azetukalner at EEC 2026 conference.
Why Consumer Health Trends Are Turning Focus To Brain Signals

Why Consumer Health Trends Are Turning Focus To Brain Signals

Exploring why brain signals are becoming central to consumer health monitoring and safety, driven by new technological and market developments.
PLT Health Solutions Brings Its Clinically Supported Branded Ingredient Platform To Vitafoods Asia

PLT Health Solutions Brings Its Clinically Supported Branded Ingredient Platform To Vitafoods Asia

PLT Health Solutions introduces its new clinically supported branded ingredient platform at Vitafoods Asia, aiming to enhance product credibility and consumer trust.
Rznomics Joins Lilly Gateway Labs In San Diego To Accelerate RNA Therapeutics

Rznomics Joins Lilly Gateway Labs In San Diego To Accelerate RNA Therapeutics

Rznomics joins Lilly Gateway Labs in San Diego to accelerate development of RNA therapeutics, marking a strategic collaboration in biotech innovation.
Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate

Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate

Orum Therapeutics has received FDA clearance for an IND application for ORM-115, a novel CD123-GSPT1 degrader-antibody conjugate, advancing its clinical pipeline.
Stay Proactive In Dental Care With Daily Gum Line Monitoring

Stay Proactive In Dental Care With Daily Gum Line Monitoring

A new approach using daily phone photos for gum health scoring aims to improve early detection of inflammation and prevent dental issues between visits.